SCHEMBL7655136

SCHEMBL7655136

O=C(O)C(c1ccccc1)N(c1ccncc1)[PH](=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 3/20 0.36
EPHX2 P34913 1/20 0.35
SRC P12931 1/20 0.35
LMNA P02545 5/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
ROCK2 O75116 1/20 0.34
RPS6KA5 O75582 1/20 0.34
MAP4K4 O95819 1/20 0.34
CDK1 P06493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650927 0.84 TSHR (0.41) SLC6A2SLC6A4SLC6A3KMT2AKDM4E
SCHEMBL7651639 0.78 TSHR (0.38) CYP2D6SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL7645872 0.71 BCHE (0.36) CYP2D6KDM4EALDH1A1MAPK1CYP2C9
SCHEMBL28275848 0.67 SRC (0.50) CYP2D6SRCLMNAMAPK1CYP1A2
SCHEMBL536278 0.66 KDM4E (0.41) SLC6A2SLC6A4SLC6A3KMT2AKDM4E
SCHEMBL536277 0.66 KDM4E (0.41) SLC6A2SLC6A4SLC6A3KMT2AKDM4E
SCHEMBL304924 0.66 KDM4E (0.41) SLC6A2SLC6A4SLC6A3KMT2AKDM4E
SCHEMBL8460780 0.66 CYP2D6 (0.50) CYP2D6SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL6803687 0.65 SLC6A2 (0.58) CYP2D6SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL1817566 0.65 SRC (0.52) CYP2D6KMT2AMEN1SRCLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed